Deficits in reward processing are evident in several psychological disorders, including anxiety, substance abuse, personality disorders, attention-deficit/hyperactivity disorder, and psychotic disorders.
Investigators sought to determine whether there exists a mechanistic association between Alzheimer disease (AD) and depression, including whether progression of depressive symptoms is related to cognitive decline during beginning stages of AD or whether depression could predict risk of developing AD.
The unique attribute of agomelatine to reset circadian rhythms might be a cause for renewed interest within the pharmaceutical and medical communities.
Depression is a major contributor to the overall global burden of disease, with more than 300 million individuals suffering from depression.1 Yet, the limited scope of therapeutics for the condition has left patients with few treatment options and low rates of remission. This may change as progress is made on the pathophysiology of depression. Indeed,…
Peer support is recognized by such bodies as the Substance Abuse and Mental Health Services Administration and the American Psychiatric Association as a valuable component of recovery-oriented services within systems of care.
Researchers in Germany found that metacognitive intervention is effective in schizophrenia, specifically for patients with schizophrenia who make quick conclusions with their thoughts that in turn reinforce their delusions. They have created and implemented the use of a computer application to facilitate metacognitive intervention, which they believe is effective for patients with mental illness.
As rates of physician burnout continue to climb, a diverse group of researchers weigh in on enhancing resilience and particularly emphasize enlightening educators about how resilience develops during residency.